Advanced search
Publication Cover
Expert Review of Precision Medicine and Drug Development
Personalized medicine in drug development and clinical practice
Volume 5, 2020 - Issue 6
Submit an article Journal homepage
870
Views
1
CrossRef citations to date
0
Altmetric
Special report

Predicting therapy response by analysis of metastasis founder cells: emerging perspectives for personalized tumor therapy

Christian WernoDivision of Personalized Tumor Therapy, Fraunhofer-Institute for Toxicology and Experimental Medicine, Regensburg, GermanyView further author information
,
Kamran HonarnejadDivision of Personalized Tumor Therapy, Fraunhofer-Institute for Toxicology and Experimental Medicine, Regensburg, GermanyView further author information
&
Bernhard PolzerDivision of Personalized Tumor Therapy, Fraunhofer-Institute for Toxicology and Experimental Medicine, Regensburg, GermanyCorrespondence[email protected]
View further author information
Pages 413-420 | Received 31 Jul 2020, Accepted 30 Sep 2020, Published online: 18 Oct 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.